Rakuten Medical, Inc., a global biotechnology company developing and commercializing its proprietary Alluminox® platform-based photoimmunotherapy, today announced the closing of a $100 million Series ...
With less than four weeks remaining before a significant policy change takes effect at airport security checkpoints ...